search
Back to results

Irrisept Spinal Fusion Pilot Study Protocol

Primary Purpose

Lumbar Spine Disease

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Irrisept Irrigation solution
Sponsored by
University of Kansas Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Lumbar Spine Disease

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18-85, undergoing primary lumbar spinal fusion (less than or equal to 3 levels)

Exclusion Criteria:

  • Prior lumbar fusion (decompression only okay), spinal infection, spinal neoplasm

Sites / Locations

  • The University of Kansas Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

normal saline control arm

Irrisept irrigation solution

Arm Description

ii. normal saline used after initial skin incision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point.

ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects

Outcomes

Primary Outcome Measures

Postoperative surgical site infections
Postop SSI
Postoperative surgical site infections
postop SSI
Postoperative surgical site infections
postop SSI
Postoperative surgical site infections
postop SSI

Secondary Outcome Measures

Fusion rates after surgery
fusion rates after surgery with irrisept vs saline irrigation
Fusion rates after surgery
fusion rates after surgery with irrisept vs saline irrigation
Fusion rates after surgery
fusion rates after surgery with irrisept vs saline irrigation
Fusion rates after surgery
fusion rates after surgery with irrisept vs saline irrigation
Patient outcome measures
Visual Analog Score for pain measuring patient outcomes in both study arms
Patient outcome measures
Visual Analog Score for pain measuring patient outcomes in both study arms
Patient outcome measures
Visual Analog Score for pain measuring patient outcomes in both study arms
Patient outcome measures
Visual Analog Score for pain measuring patient outcomes in both study arms
Patient outcome measures
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Patient outcome measures
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms

Full Information

First Posted
July 30, 2021
Last Updated
August 16, 2021
Sponsor
University of Kansas Medical Center
Collaborators
Irrimax Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT05011942
Brief Title
Irrisept Spinal Fusion Pilot Study Protocol
Official Title
Irrisept Spinal Fusion Pilot Study Protocol
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2021 (Anticipated)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Kansas Medical Center
Collaborators
Irrimax Corporation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Study objectives include assessing the use of Irrisept irrigation solution in lumbar spinal fusion procedures and effect on clinical and patient reported outcome measures. This includes assessing postoperative SSI as well as fusion rates in addition to patient reported outcome measures.
Detailed Description
This is a randomized controlled pilot study with a study size of 50 patients. Results will be utilized to plan a larger scale study. Background literature supports the use of chlorhexidine gluconate as an irrigation solution to decrease SSI although this has not been conducted in this population of patients (lumbar spine fusion) to date. A decrease in SSI with Irrisept, could support the possible use of this as an irrigation solution to decrease infections postoperatively. It will be important to know the effect if any of Irrisept on fusion rates. This study will provide valuable information that may assist in future treatment and prevention of SSI in lumbar spinal fusion patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Spine Disease

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This is a randomized 1:1 treatment of placebo or standard of care irrigation and Irrisept solution.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
normal saline control arm
Arm Type
Placebo Comparator
Arm Description
ii. normal saline used after initial skin incision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point.
Arm Title
Irrisept irrigation solution
Arm Type
Active Comparator
Arm Description
ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects
Intervention Type
Device
Intervention Name(s)
Irrisept Irrigation solution
Intervention Description
ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects v. Normal saline irrigation will be used alone in control subjects at the same time points.
Primary Outcome Measure Information:
Title
Postoperative surgical site infections
Description
Postop SSI
Time Frame
assessed for change at 1 month
Title
Postoperative surgical site infections
Description
postop SSI
Time Frame
assessed for change at 3 months
Title
Postoperative surgical site infections
Description
postop SSI
Time Frame
assessed for change at 6 months
Title
Postoperative surgical site infections
Description
postop SSI
Time Frame
assessed for change at 12 months
Secondary Outcome Measure Information:
Title
Fusion rates after surgery
Description
fusion rates after surgery with irrisept vs saline irrigation
Time Frame
assessed at 1 month
Title
Fusion rates after surgery
Description
fusion rates after surgery with irrisept vs saline irrigation
Time Frame
assessed for change at 3 months
Title
Fusion rates after surgery
Description
fusion rates after surgery with irrisept vs saline irrigation
Time Frame
assessed for change at 6 months
Title
Fusion rates after surgery
Description
fusion rates after surgery with irrisept vs saline irrigation
Time Frame
assessed for change at 12 months
Title
Patient outcome measures
Description
Visual Analog Score for pain measuring patient outcomes in both study arms
Time Frame
assessed at 1 month
Title
Patient outcome measures
Description
Visual Analog Score for pain measuring patient outcomes in both study arms
Time Frame
assessed at 3 months
Title
Patient outcome measures
Description
Visual Analog Score for pain measuring patient outcomes in both study arms
Time Frame
assessed at 6 months
Title
Patient outcome measures
Description
Visual Analog Score for pain measuring patient outcomes in both study arms
Time Frame
assessed at 12 months
Title
Patient outcome measures
Description
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 1 month
Title
Patient outcome measures
Description
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 3 months
Title
Patient outcome measures
Description
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 6 months
Title
Patient outcome measures
Description
Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 12 months
Title
Patient outcome measures
Description
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 1 month
Title
Patient outcome measures
Description
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 3 months
Title
Patient outcome measures
Description
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 6 months
Title
Patient outcome measures
Description
Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms
Time Frame
assessed at 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18-85, undergoing primary lumbar spinal fusion (less than or equal to 3 levels) Exclusion Criteria: Prior lumbar fusion (decompression only okay), spinal infection, spinal neoplasm
Facility Information:
Facility Name
The University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66106
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joshua Bunch, MD
Phone
913-588-6100
Email
jbunch2@kumc.edu
First Name & Middle Initial & Last Name & Degree
Stephanie Robinson, MS
Phone
9137091416
Email
srobinson6@kumc.edu
First Name & Middle Initial & Last Name & Degree
Joshua Bunch, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Irrisept Spinal Fusion Pilot Study Protocol

We'll reach out to this number within 24 hrs